SBASX | VEXRX | SBASX / VEXRX | |
Total Expense Ratio | 0.99 | 0.33 | 300% |
Annual Report Gross Expense Ratio | 1.13 | 0.33 | 342% |
Fund Existence | 6 years | 24 years | - |
Gain YTD | 1.981 | 5.456 | 36% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250000 | 50000 | 500% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 95.7M | 20.6B | 0% |
Annual Yield % from dividends | 0.22 | 0.49 | 44% |
Returns for 1 year | -3.66 | -2.74 | 134% |
Returns for 3 years | 29.63 | 32.16 | 92% |
Returns for 5 years | 22.64 | 3.48 | 650% |
Returns for 10 years | N/A | 34.59 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JCVIX | 25.32 | 0.43 | +1.73% |
JHancock Classic Value I | |||
SBHIX | 24.28 | 0.14 | +0.58% |
Saratoga Health & Biotechnology I | |||
ETLAX | 15.81 | 0.03 | +0.19% |
Eventide Large Cap Focus A | |||
EKBAX | 15.66 | -0.06 | -0.38% |
Allspring Diversified Cap Bldr A | |||
PRJQX | 49.66 | -0.45 | -0.90% |
PGIM Jennison Global Opportunities R6 |